Home > Boards > US Listed > Medical - Drugs > Catabasis Pharmaceuticals (CATB)

Hi Dr.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
K The New Investor Member Profile
 
Followed By 1
Posts 13
Boards Moderated 0
Alias Born 07/28/16
160x600 placeholder
Catabasis Pharmaceuticals to Present During the Virtual 25th International Congress of the World Muscle Society Business Wire - 9/23/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/21/2020 8:11:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2020 8:09:13 AM
Catabasis Pharmaceuticals Names Noah Clauser Chief Financial Officer Business Wire - 9/21/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present at Upcoming Virtual Investor Conferences Business Wire - 9/8/2020 8:00:00 AM
Catabasis Pharmaceuticals to Host Virtual KOL Event on Edasalonexent and Duchenne Muscular Dystrophy Business Wire - 9/2/2020 8:00:00 AM
Catabasis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Reviews Business Progress Business Wire - 8/10/2020 4:10:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:01:26 PM
Catabasis Pharmaceuticals to Present at Virtual 2020 Wedbush PacGrow Healthcare Conference Business Wire - 8/5/2020 8:00:00 AM
Catabasis Pharmaceuticals & Bill & Melinda Gates Medical Research Institute to Study CAT-5571 in Drug-Sensitive & Drug-Resist... Business Wire - 8/4/2020 8:00:00 AM
Catabasis Pharmaceuticals to Report Second Quarter 2020 Financial Results on Monday, August 10th Business Wire - 7/27/2020 8:00:00 AM
Catabasis Pharmaceuticals to Present at Parent Project Muscular Dystrophy Virtual Annual Conference Business Wire - 7/15/2020 8:00:00 AM
 Catabasis Joins Russell 3000® Index Business Wire - 6/29/2020 4:10:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:57:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:46:47 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:45:58 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:45:24 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 11:34:43 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 6/12/2020 8:12:53 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2020 8:10:59 AM
Catabasis Pharmaceuticals Names Ben Harshbarger Senior Vice President, General Counsel Business Wire - 6/12/2020 8:00:00 AM
Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business Progress Business Wire - 5/12/2020 4:10:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/12/2020 4:02:14 PM
Catabasis Pharmaceuticals Presents Edasalonexent, a Potential Foundational Therapy for Duchenne Muscular Dystrophy Business Wire - 5/12/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/28/2020 4:11:47 PM
K The New Investor   Wednesday, 10/26/16 10:23:46 AM
Re: Dr_Thorfin post# 35
Post # of 221 
Hi Dr.

So CATB did fall below 4.50 yesterday. I saw that on OCt 20 it would take 11 days for shorts to cover - a whole bunch of scenarios. I would expect since the gap is 'closed' now the stock price should rise and esp after Oct 31 (if shorts are adding more to their short position.

Wondering where your thoughts are now?

Would love to hear from anyone out there. CATAB doesn't get much press fr the analysts and trading volume is low. Thisis a hard one to judge...but then again, I am new...smile

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences